Trends in Management and Outcomes of Acute Nonvariceal Upper Gastrointestinal Bleeding: 1993–2003  Laura E. Targownik, Alice Nabalamba  Clinical Gastroenterology and Hepatology  Volume 4, Issue 12, Pages 1459-1466.e1 (December 2006) DOI: 10.1016/j.cgh.2006.08.018 Copyright © 2006 AGA Institute Terms and Conditions

Figure 1 Trends in the incidence of ANVUGIB in Canada between 1993 and 2003. Clinical Gastroenterology and Hepatology 2006 4, 1459-1466.e1DOI: (10.1016/j.cgh.2006.08.018) Copyright © 2006 AGA Institute Terms and Conditions

Figure 2 Trends in the incidence of ANVUGIB (strict definition) in Canada between 1993 and 2003, stratified by age. -+-, 18–39 y; -x-, 40–59 y; ▴, 60–69 y; , 70–79 y; ■, 80+ y. Clinical Gastroenterology and Hepatology 2006 4, 1459-1466.e1DOI: (10.1016/j.cgh.2006.08.018) Copyright © 2006 AGA Institute Terms and Conditions

Figure 3 Proportion of ANVUGIB patients receiving upper-gastrointestinal surgery for control of bleeding. -+-, overall surgery; ■, category A surgery; •, category B surgery. Clinical Gastroenterology and Hepatology 2006 4, 1459-1466.e1DOI: (10.1016/j.cgh.2006.08.018) Copyright © 2006 AGA Institute Terms and Conditions

Figure 4 Mortality rates for ANVUGIB patients in the hospital between 1993–1994 and 2002–2003, stratified by age. -x-, 18–59 y; ▴, 60–69 y; , 70–79 y; ■, 80+ y; - - • - -, overall. Clinical Gastroenterology and Hepatology 2006 4, 1459-1466.e1DOI: (10.1016/j.cgh.2006.08.018) Copyright © 2006 AGA Institute Terms and Conditions

Figure 5 Trends in the LOHS: 1993–1994 to 2002–2003. •, 18–59 y; ▴, 60–69 y; , 70–79 y; ■, 80+ y; - - - -, overall. Clinical Gastroenterology and Hepatology 2006 4, 1459-1466.e1DOI: (10.1016/j.cgh.2006.08.018) Copyright © 2006 AGA Institute Terms and Conditions

Figure 6 Proportion of ANVUGIB subjects with LOHS of less than 48 hours or more than 7 days: 1993–1994 to 2002–2003. •, LOHS ≤ 2 days; ▴, LOHS ≥ 5 days. Clinical Gastroenterology and Hepatology 2006 4, 1459-1466.e1DOI: (10.1016/j.cgh.2006.08.018) Copyright © 2006 AGA Institute Terms and Conditions